Changchun BCHT Biotechnology Co. (SHA:688276)
19.00
+0.25 (1.33%)
Mar 10, 2026, 3:00 PM CST
SHA:688276 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 7,859 | 7,802 | 10,387 | 22,628 | 28,531 | 28,321 | Upgrade
|
| Market Cap Growth | -19.66% | -24.89% | -54.10% | -20.69% | 0.74% | - | Upgrade
|
| Enterprise Value | 7,977 | 7,919 | 10,172 | 22,168 | 27,501 | 27,236 | Upgrade
|
| Last Close Price | 19.00 | 18.86 | 24.91 | 54.15 | 68.11 | 67.49 | Upgrade
|
| PE Ratio | - | - | 44.75 | 45.16 | 157.17 | 116.28 | Upgrade
|
| Forward PE | - | 11.12 | 13.55 | 32.89 | 55.21 | 44.22 | Upgrade
|
| PS Ratio | 13.28 | 13.18 | 8.45 | 12.40 | 26.63 | 23.56 | Upgrade
|
| PB Ratio | 1.99 | 1.97 | 2.46 | 5.63 | 8.02 | 8.29 | Upgrade
|
| P/TBV Ratio | 2.17 | 2.15 | 2.67 | 6.16 | 8.50 | 8.87 | Upgrade
|
| P/OCF Ratio | - | - | 25.55 | 88.67 | 716.54 | 201.86 | Upgrade
|
| EV/Sales Ratio | 13.48 | 13.38 | 8.28 | 12.15 | 25.67 | 22.66 | Upgrade
|
| EV/EBITDA Ratio | - | - | 28.66 | 34.97 | 119.12 | 88.50 | Upgrade
|
| EV/EBIT Ratio | - | - | 40.57 | 40.90 | 171.96 | 113.75 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.02 | 0.01 | - | - | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.29 | 0.03 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.03 | -0.06 | -0.10 | -0.24 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.45 | -0.45 | -0.68 | -0.66 | -3.75 | -3.75 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 1.78 | 1.96 | 3.45 | 2.35 | Upgrade
|
| Asset Turnover | - | - | 0.24 | 0.39 | 0.25 | 0.36 | Upgrade
|
| Inventory Turnover | - | - | 1.11 | 1.08 | 0.84 | 1.18 | Upgrade
|
| Quick Ratio | - | - | 1.91 | 1.98 | 2.56 | 2.56 | Upgrade
|
| Current Ratio | - | - | 2.14 | 2.21 | 2.87 | 2.93 | Upgrade
|
| Return on Equity (ROE) | -6.66% | -6.66% | 5.63% | 13.22% | 5.20% | 9.37% | Upgrade
|
| Return on Assets (ROA) | - | - | 3.06% | 7.26% | 2.36% | 4.51% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.90% | -9.01% | 6.01% | 15.26% | 5.93% | 11.95% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 5.80% | 13.40% | 4.50% | 7.00% | Upgrade
|
| Earnings Yield | -3.46% | -3.49% | 2.23% | 2.21% | 0.64% | 0.86% | Upgrade
|
| FCF Yield | - | - | -1.31% | -0.95% | -0.88% | -1.74% | Upgrade
|
| Dividend Yield | 0.90% | - | 0.68% | 0.28% | 0.22% | 0.15% | Upgrade
|
| Payout Ratio | - | - | 26.73% | 12.50% | 22.74% | - | Upgrade
|
| Buyback Yield / Dilution | 0.54% | 0.54% | -0.10% | -0.36% | -5.03% | -7.07% | Upgrade
|
| Total Shareholder Return | 1.43% | 0.54% | 0.58% | -0.08% | -4.81% | -6.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.